Suppr超能文献

缺血性左心室衰竭心肌血运重建后的功能结局。

Functional outcome after myocardial revascularization in ischemic left ventricular failure.

作者信息

Luciani G B, Montalbano G, Casali G, Faggian G, Mazzucco A

机构信息

Division of Cardiac Surgery, University of Verona.

出版信息

G Ital Cardiol. 1998 Aug;28(8):859-65.

PMID:9773310
Abstract

BACKGROUND

Myocardial revascularization in patients with left ventricular failure (ejection fraction < 30%) offers survival comparable to heart transplantation. The functional outcome, however, has yet to be determined. In order to assess the clinical results in patients with LVEF < 30% undergoing coronary artery bypass grafts (CABG), 101 consecutive patients operated between 1/91 and 1/97 were reviewed retrospectively.

METHODS

The patients were stratified according to presentation: 65 pts had angina (Group 1) and 36 congestive failure (Group 2). Mean age (62 +/- 7 vs 60 +/- 8 yrs), sex (90 vs 88% male), LVEF (0.28 +/- 0.04 vs 0.29 +/- 0.04), prior myocardial infarction (1.2 +/- 0.4 vs 1.2 +/- 0.5 episodes/pt), presence of vital myocardium at scintiscan or low-dose dobutamine echocardiography (92 vs 93%), need for preoperative IABP (3.1 vs 8.3%), aortic cross-clamp (53 +/- 21 vs 60 +/- 21 min) and cardiopulmonary bypass (104 +/- 31 vs 114 +/- 36 min) times were comparable.

RESULTS

There was only 1 (1%) perioperative death due to low-output syndrome. Eleven pts (6 vs 5, Group 1 vs Group 2) had postoperative low-output syndrome, requiring IABP in 7 pts (4 vs 3). There were 14 (10 vs 4, Group 1 vs Group 2) deaths during follow-up (29 +/- 19 months, range 2-67), with an overall actuarial survival of 91 +/- 4 vs 100% at 1 yr and 74 +/- 9 vs 78 +/- 10% at 5 yrs in Group 1 vs Group 2, respectively (p = ns). Actuarial symptom-free survival was 89 +/- 4 vs 84 +/- 6% at 1 yr and 49 +/- 9 vs 28 +/- 11% at 5 yrs, respectively (p = 0.05). Despite the high recurrence of congestive failure (22 vs 66% in Group 1 vs Group 2, p = 0.004), improvement in functional class (3.1 +/- 0.8 vs 1.5 +/- 0.7 in Group 1 and 2.7 +/- 0.7 vs 1.8 +/- 0.5 in Group 2) and LVEF (0.28 +/- 0.04 vs 0.38 +/- 0.04 in Group 1 and 0.29 +/- 0.04 vs 0.40 +/- 0.06 in Group 2) was found in both groups at follow-up.

CONCLUSIONS

In spite of improving early and late survival after revascularization for ischemic left ventricular failure, patients presenting with congestive failure have an unsatisfactory symptom-free survival. Further studies are necessary to ascertain the relative indications to revascularization or transplantation in this specific patient subgroup.

摘要

背景

左心室衰竭(射血分数<30%)患者的心肌血运重建术可提供与心脏移植相当的生存率。然而,其功能结局尚未确定。为了评估左心室射血分数(LVEF)<30%的患者接受冠状动脉旁路移植术(CABG)的临床结果,我们回顾性分析了1991年1月至1997年1月期间连续接受手术的101例患者。

方法

根据临床表现对患者进行分层:65例患者有胸痛(第1组),36例有充血性心力衰竭(第2组)。平均年龄(62±7岁对60±8岁)、性别(男性分别为90%对88%)、LVEF(0.28±0.04对0.29±0.04)、既往心肌梗死(1.2±0.4次/患者对1.2±0.5次/患者)、心肌灌注显像或小剂量多巴酚丁胺超声心动图显示存活心肌的情况(92%对93%)、术前是否需要主动脉内球囊反搏(IABP)(3.1%对8.3%)、主动脉阻断时间(53±21分钟对60±21分钟)和体外循环时间(104±31分钟对114±36分钟)均具有可比性。

结果

围手术期仅1例(1%)因低心排血量综合征死亡。11例患者(第1组6例,第2组5例)术后出现低心排血量综合征,其中7例(第1组4例,第2组3例)需要IABP支持。随访期间(29±19个月,范围2 - 67个月)共有14例死亡(第1组10例,第2组4例),第1组和第2组1年的总体预期生存率分别为91±4%对100%,5年分别为74±9%对78±10%(p=无统计学意义)。1年和5年的无症状预期生存率分别为89±4%对84±6%(p = 0.05)和49±9%对28±11%。尽管充血性心力衰竭复发率较高(第1组22%对比第2组66%,p = 0.004),但随访时两组患者的心功能分级均有改善(第1组从3.1±0.8改善至1.5±0.7,第2组从2.7±0.7改善至1.8±0.5),LVEF也有改善(第1组从0.28±0.04改善至0.38±0.04,第2组从0.29±0.04改善至0.40±0.06)。

结论

尽管缺血性左心室衰竭血运重建术后的早期和晚期生存率有所提高,但出现充血性心力衰竭的患者无症状生存率仍不理想。有必要进一步研究以确定这一特定患者亚组中行血运重建术或移植术的相对适应证。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验